# Modeling Stress-precipitated Smoking Behavior for Medication Development

> **NCT00773357** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 100 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** guanfacine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00773357
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773357, "Modeling Stress-precipitated Smoking Behavior for Medication Development". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00773357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*